Cite

HARVARD Citation

    Egeberg, A. et al. (2018). Safety, efficacy and drug survival of biologics and biosimilars for moderate‐to‐severe plaque psoriasis. British journal of dermatology. pp. 509-519. [Online]. 
  
Back to record